unknown by Susan A. Farr et al.
The antioxidants a-lipoic acid and N-acetylcysteine reverse
memory impairment and brain oxidative stress in aged SAMP8
mice
Susan A. Farr,*
,  H. Fai Poon,  Dilek Dogrukol-Ak,§ Jeniffer Drake,  William A. Banks,*
Edward Eyerman,* D. Allan Butterﬁeld  and John E. Morley*
*Geriatric Research Education and Clinical Center (GRECC), VA Medical Center, St. Louis, Missouri, USA
 Department ofInternal Medicine, Division ofGeriatric Medicine, St. Louis University School ofMedicine, St. Louis, Missouri, USA
 Department ofChemistry, Center ofMembrane Sciences, and Sander-Brown Center on Aging, University ofKentucky, Lexington,
Kentucky, USA
§Anadolu University, Faculty ofPharmacy, Department ofAnalytical Chemistry, Eskisehir, Turkey
Abstract
Oxidative stress may play a crucial role in age-related neuro-
degenerative disorders. Here, we examined the ability of two
antioxidants, a-lipoic acid (LA) and N-acetylcysteine (NAC), to
reverse the cognitive deﬁcits found in the SAMP8 mouse. By
12 months of age, this strain develops elevated levels of Ab
and severe deﬁcits in learning and memory. We found that
12-month-old SAMP8 mice, in comparison with 4-month-old
mice, had increased levels of protein carbonyls (an index of
protein oxidation), increased TBARS (an index of lipid peroxi-
dation) and a decrease in the weakly immobilized/strongly
immobilized (W/S) ratio of the protein-speciﬁc spin label MAL-6
(an index of oxidation-induced conformational changes in
synaptosomal membrane proteins). Chronic administration of
either LA or NAC improved cognition of 12-month-old SAMP8
mice in both the T-maze footshock avoidance paradigm and
the lever press appetitive task without inducing non-speciﬁc
effects on motor activity, motivation to avoid shock, or body
weight. These effects probably occurred directly within the
brain, as NAC crossed the blood–brain barrier and accumu-
lated in the brain. Furthermore, treatment of 12-month-old
SAMP8 mice with LA reversed all three indexes of oxidative
stress. These results support the hypothesis that oxidative
stress can lead to cognitive dysfunction and provide evidence
for a therapeutic role for antioxidants.
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Free radical damage from oxidative stress has long been
thought to play an important role in age-related neurodegen-
erative disorders (Harman 1995). It has been suggested that
free radical damage compromises composition integrity of
cell membranes, which decreases membrane ﬂuidity
(Zs-Nagy 1990). Although the speciﬁc mechanism for free
radical generation and consequent oxidative stress differ
between normal aging and neurodegenerative diseases, a
consensus is emerging that free radical processes do play an
important role in the etiology of many disorders (Hensley
et al. 1995a; Butterﬁeld and Stadtman 1997; Butterﬁeld
et al. 2001a; Butterﬁeld and Lauderback 2002). Free radical-
mediated damage to neuronal membrane components has
been implicated in the etiology of diseases of aging such as
Alzheimer’s disease (AD). For example, the molecular basis
of AD is unclear, but numerous lines of genetic and
biochemical evidence suggest that a 39–43 amino acid
peptide, amyloid b peptide (Ab) that is the principal
component of senile plaques in the AD brain, is central to
the pathogenesis of AD (Butterﬁeld et al. 2001a; Butterﬁeld
et al. 2001b; Butterﬁeld and Lauderback 2002). Ab is
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neurons in vitro (Varadarajan et al. 2001; Yatin et al. 1999;
Varadarajan et al. 2000; Kanski et al. 2002).
Oxidative stress can probably result in cognitive impair-
ments. Antioxidants have been found to both prevent and
reverse learning and memory deﬁcits induced by free radicals
(Bickford et al. 2000; Kastin et al. 1979; Introini et al. 1985;
Shih et al. 1986; Jankovic et al. 1990; Guerrero et al. 1999;
Abe and Saito 2000; Emilien et al. 2000; Rivas-Arancibia
et al. 2000). a-Lipoic acid (LA) and N-acetylcysteine (NAC)
are two antioxidants used to combat oxidative stress-induced
damage (Nagamatsu et al. 1995; Yao et al. 1989; Maziere
et al. 1999). Studies indicate that both LA and NAC protect
against oxidative stress in peripheral tissues and in the central
nervous system (Maziere et al. 1999; Yehuda and Youdim
1981; Drust and Crawford 1983; Greeley et al. 1989;
Stoll et al. 1993; Packer et al. 1997; Martinez et al. 2000;
Pocernichet al.2002).Inaddition,bothcompoundshavebeen
foundtoreverseage-relatedimpairmentsinmemory(Martinez
et al. 2000; Yehuda and Youdim 1981; Stoll et al. 1993) and
LA prevents the increase in lipid peroxidase levels that occurs
with age (Arivazhagan et al. 2000).
The SAMP8 strain of mice develops deﬁcits in learning and




(APP) (Morley et al. 2000; Cserr 1984; Kumar et al. 2000;
Morleyet al.2002).DecreasingAbwithantibodyorantisense
in12-month-oldSAMP8miceimproveslearningandmemory
(VanBreeet al.1990;Kumaret al.2000;Morleyet al.2000).
In addition, SAMP8 mice have been found to have increased
free radical production in the central nervous system (Sato
et al. 1996; Butterﬁeld et al. 1997) associated with mito-
chondrial dysfunction (Fujibayashi et al. 1998). In the current
study, we examined the effects of two potent antioxidants, LA
and NAC, on acquisition in the T-maze footshock avoidance
taskandleverpressappetitivetask,theabilityofNACtocross
theblood–brainbarrier(BBB),andtheabilityofLAtoreverse
markers of oxidative stress.
Materials and methods
Subjects
Experimentally naive, 4- and 12-month-old male SAMP8 mice were
obtained from our breeding colony. The colony is derived from
siblings generously provided by Dr Takeda of (Kyoto University,
Japan), and has been maintained as an inbred strain for 12 years
under clean-room procedures (i.e. use of sterile gloves in handling
mice, sterilized cages and bedding, restricted access to breeding
area), and housed in microisolator HEPA ﬁlter units (Allentown
Caging, PA, USA). The colony routinely undergoes serological
testing for viral and bacterial contamination and has remained free
of pathogens for over 5 years. Mice are housed in rooms with a
12 : 12 light/dark cycle (lights on at 06.00 h) at 20–22 C with water
and food (Richmond Laboratory Rodent Diet 5001) available
ad libitum. All experiments were conducted after institutional
approval of the animal use subcommittee, which subscribes to the
NIHGuide for Care and Use of Laboratory Animals.
Drug administration
LA and NAC were a gift from Jarrow Formulas, Inc. (Los Angeles,
CA, USA). All drugs were dissolved in saline at pH7.0. LA
(100 mg/kg), NAC (100 mg/kg), or saline were administered
subcutaneously once daily for 4 weeks at 1 PM. At the end of week
one, animals were tested in the T-maze footshock avoidance
paradigm. The following day, activity was tested in an open ﬁeld
and a 1-week habituation to milk was begun. At the end of the
1-week habituation, mice were trained in the lever press. Behavioral
measures and training were conducted between 07.30 and 11.30 h.
T-maze training
Training procedures for the T-maze footshock avoidance apparatus
have been described (Farr et al. 1999, 2000). The maze consisted of
a black plastic start alley with a start box at one end and two goal
boxes at the other. A stainless steel rod ﬂoor ran throughout the
maze. The start box was separated from the start alley by a plastic
guillotine door that prevented the mouse from moving down the
alley until the training started.
A training trial began when a mouse was placed into the start box.
The guillotine door was raised and the buzzer was sounded
simultaneously; 5 s later, footshock was applied. The goal box the
mouse ﬁrst entered on the ﬁrst trial was designated as  incorrect .
Footshock was continued until the mouse entered the other goal box,
which on all subsequent trials was designated  correct  for the
particular mouse. At the end of each trial, the mouse was removed
from the goal box and returned to itshome cage. Anew trial began by
placing the mouse back in the start box, sounding the buzzer, and
raising the guillotine door. Footshock was applied 5 s later if the
mousedidnotleavethestartboxorfailedtoenterthecorrectgoalbox.
Training used an intertrial interval of 45 s and a door-bell type
buzzer at 65 dB as the conditioned stimulus warning of onset of foot
shock at 0.40 mA (Coulbourn Instruments scrambled grid ﬂoor
shocker model E13-08). Mice were trained until they made one
avoidance.
Open ﬁeld
In order to eliminate the possibility that differences in acquisition
were produced by changes in activity in treated mice, we examined
activity in an open ﬁeld. Mice were given one trial each in which
they were allowed to explore freely in an open ﬁeld for 15 min to
determine their activity level. The open ﬁeld apparatus consisted of
a circular ﬁeld 45 cm in diameter with sides that were 30 cm high.
A testing session started with the entrance of the mouse into the side
of the ﬁeld facing the wall. The distances each mouse traveled
during the single 15 min session were recorded in centimeters using
a Polytrak recording system (San Diego Instruments).
Habituation to milk solution
Appetitive tasks used a solution of one part evaporated milk and two
parts water. Mice were initially habituated to this novel food by
allowing them access to it in their home cages overnight. During
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encourage drinking of the milk solution. After the third session,
mice not consuming at least 20 mL of milk solution were excluded
(less than 10% of the population). In appetitive training tasks, mice
were run after overnight food and water deprivation.
Acquisition of lever press for milk reinforcement
Mice were placed into a fully automated lever press chamber.
Pressing a lever on one wall of the compartment caused a light and
liquid dipper with 100 lL of milk to appear on the opposite wall.
On days 1 and 2, mice had 11 s to obtain the reward; on days 3 and
4, mice had 7 s to obtain the reward; on all subsequent days, mice
had 4 s to obtain a reward. Mice were given a 30-min training
session each day until all groups in the particular study received an
average of 100 rewards in a 30-min session. The measure of
acquisition was the number of reinforced lever presses.
Blood–brain barrier studies
[
14C]N-Acetylcysteine (C-NAC) with a speciﬁc activity of
55 mCi/mmol was purchased from ICN Biomedicals, Inc. (Irvine,
CA, USA). Bovine serum albumin was labeled with
99mTc (T-Alb)
by adding 0.12 mg of stannous tartrate and 1 mg of bovine serum
albumin to 1-mL distilled water. The pHwas adjusted to 2.5–3.3
with 0.2 M HCl. The mixture was incubated at room temperature
(22 C) for 20 min before use.
Measurement of inﬂux into brain
The unidirectional inﬂux rate (Ki) from blood to brain was
determined in mice by multiple-time regression analysis (Blasberg
et al. 1983; Patlak et al. 1983; Kastin et al. 2001). Male ICR mice
weighing 20–25 g were anesthetized with urethane and the left
jugular vein and right carotid artery exposed. Mice received an
injection into the jugular vein of 0.2 mL of lactated Ringer’s
solution with 1% bovine serum albumin and 2 (10
6) cpm of
(C-NAC). Arterial blood was collected at 2, 3, 5, 7.5, 10, 15 or
20 min after intravenous injection through a cut in the carotid artery.
Mice were immediately decapitated after collection of arterial blood
and the whole brain removed. Whole blood was centrifuged at
5000 g at 4 C for 10 min and 50 lL removed. The levels of
radioactivity in serum and brain were determined in a beta counter.
The Ki, expressed in lL/g/min, and the apparent volume of









where Am is cpm/g of brain, Cpt is cpm/lL of arterial serum at time
t, and T is the dummy variable for time. Am/Cpt is the brain/blood
ratio in lL/g and exposure time is measured by the term [it
o Cp(T)
dT]/Cpt. Only the linear portion of the relation between Am/Cpt
versus exposure time is used to compute Ki and Vi. The percentage
of the intravenously injected dose taken up per gram of brain was
determined from the equation:
%Inj=g ¼ 10 3ðAm=CptÞð%Inj=mLÞ:
Capillary depletion
Mice received intravenous injections of 6.6 (10
6) cpm of (C-NAC)
and 10
6 cpm of T-Alb. Ten minutes after intravenous injection, the
vascular space of the brain was washed free of blood. This washout
was preceded by opening the abdomen and taking an arterial blood
sample from a cut in the abdominal aorta. The jugular veins were
than severed, the thorax opened, and 20 mL of lactated Ringer’s
solution perfused through the left ventricle of the heart while the
descending thoracic aorta was occluded. Washout took less than
1 min. After washout, the mouse was immediately decapitated and
the cerebral cortex removed, weighed, and homogenized with a
glass homogenizer (10 strokes) in 0.8 mL of physiological buffer
(10 mM Hepes, 141 mM NaCl, 4 mM KCl, 2.8 mM CaCl2,1m M
MgSO4,1m M NaH2PO4 and 10 mMD-glucose adjusted to pH7.4).
Dextran solution (1.6 mL of a 26% solution) was added to the
homogenate, which was vortexed and homogenized again (three
strokes). Homogenization was performed on ice before centrifuging
at 5400 g for 15 min at 4 C in a Beckman Allegra 21R centrifuge
with a swinging bucket rotor (Fullenton, CA, USA). The pellet
containing brain capillaries and the supernatant representing the
brain parenchymal/brain interstitial ﬂuid space were carefully
separated and the levels of radioactivity determined in gamma and
beta counters for
99mTc and
14C, respectively. Levels of
14C and
99mTc were also measured in serum. Levels of
14C were determined
after degradation of
99mTc to non-detectable levels. The fractions
were expressed as volumes of distribution (lL/g).
Oxidative stress measures
SAMP8 brain samples were ﬂash frozen in liquid nitrogen in
St. Louis and sent to Lexington on wet ice overnight. The samples
were homogenized in 0.32 M sucrose isolation buffer (2 mM EDTA,
2m M EGTA, 20 mM Hepes, 20 lg/mL trypsin inhibitor, 4 lg/mL
leupeptin, 4 lg/mL pepstatin, 5 lg/mL aprotinin) by sonication and
the protein concentration was determined by the BCA method.
Three indices of oxidative stress were used: (i) protein carbonyl
levels, which index protein oxidation (Butterﬁeld and Stadtman
1997); (ii) the weakly immobilized/strongly immobilized (W/S)
ratio of the protein-speciﬁc spin label MAL-6, which when bound to
synaptosomal membrane proteins yields a lower value of the W/S
ratio, indexing oxidative stress-induced alterations in membrane
protein conformation (Hensley et al. 1994; Butterﬁeld and Stadtman
1997); and (iii) thiobarbituric acid reactive substance (TBARS), an
index of lipid peroxidation. Protein carbonyl levels have been
shown to be increased in aging (Butterﬁeld et al. 1997; Hensley
et al. 1994; Butterﬁeld and Stadtman 1997). The W/S ratio is an
EPR parameter reﬂective of protein–protein interactions, which
decreases in oxidative stress (Hensley et al. 1994). The W/S ratio is
the ratio of intensity of the MI ¼ +1 low-ﬁeld weakly immobilized
line and MI ¼ +1 low-ﬁeld strongly immobilized resonance line of a
protein-speciﬁc spin label, MAL-6 (Butterﬁeld 1982). TBARS
provide a measure of lipid peroxidation damage (Ohkawa et al.
1979) that was shown to be involved in aging (Tappel 1968; Harman
1969) because of the high reactivity of thiobarbituric acid with the
lipid peroxidation end product, malondialdehyde (Ohkawa et al.
1979).
Carbonyl level
Protein carbonyl levels of proteins were determined immunochem-
ically as adducts of 2,4-dinitrophenylhydrazine (Oliver et al. 1987).
Five microliters of the samples were treated with an equal volume of
12% sodium dodecyl sulfate (SDS). Samples were then derivatized
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stopped by addition of neutralizing reagent (7.5 lLo f2M Tris/30%
glycerol buffer, pH ¼ 8.0). Levels of protein carbonyls were
measured by using the slot-blot technique with 250 ng of protein
loaded per slot. The 2,4-dinitrophenyl hydrazone (DNP) adduct of
the carbonyls is detected on the nitrocellulose paper using a primary
rabbit antibody (Intergen) speciﬁc for DNP-protein adducts (1 : 100)
and then a secondary goat anti-rabbit IgG (Sigma) antibody. The
resulting stain was developed by SCION-IMAGE software package.
TBARS
The concentration of TBARS in brain tissue was determined
according to the method of Ohkawa et al. (1979). Fifty milliliters of
10% w/v of ice cold trichloroacetic acid was added into 0.25 mL of
4 mg/mL tissue homogenate. The samples were spun in an
Eppendorf centrifuge tube for 5 min at 3000 g. The supernatant
was collected (0.5 mL) and treated with TBA reagent (20 mM TBA
in 50% v/v glacial acetic acid). The samples were then heated at
100 C for 1 h. After the cooling period, butanol was added, and the
organic layer was removed and redistributed to a black microtiter
plate (Corning Inc, Acton, MA, USA). End point ﬂuorescence was
measured at kex ¼ 515 nm and kem ¼ 585 nm.
W/S ratio
Synaptosomes were puriﬁed as described (Butterﬁeld et al. 1994;
Hensley et al. 1994; Hensley et al. 1995b). The crude homogenate
was removed and respun at 20 000 g at 4 C for 10 min. The
resulting pellet was resuspended in the 0.32 M sucrose isolation
buffer and layered on a discontinuous sucrose gradient (10 mL of
1.18 M sucrose, pH8.5/10 mL of 1.0 M sucrose, pH7.4/10 mL of
0.85 M sucrose, pH7.4, each containing 2 m M EDTA/2 mM EGTA/
10 mM Hepes). The samples were then spun at 82 500 g at 4 C for
60 min in a Beckman swinging-bucket rotor. Synaptosomes were
removed from the 1.18/1.0 M sucrose interface and resuspended in
20 mL of lysing buffer (10 mM Hepes/2 mM EDTA/2 mM EGTA,
pH7.4). The samples were then centrifuged at 32 000 g at 4 C for
10 min. The pellet was removed and resuspended in PBS buffer and
spun down twice more. After the third wash, the protein
concentration was determined by the BCA method.
Spin labeling of synaptosomal membrane proteins was per-
formed as described (Umhauer et al. 1992; Hensley et al. 1994).
Isolated synaptosomes were suspended in lysing buffer for 30 min.
Lysed synaptosomal membranes were labeled with the protein-
speciﬁc spin label MAL-6. After incubation for 18 h at 4 C with
20 lg MAL-6/mg protein, samples were washed six times in
lysing buffer to remove excess spin label. The pellet was then
resuspended in approximately 400 lL lysing buffer and allowed to
come to room temperature. EPR spectra were acquired on a Bruker
model EMX EPR spectrometer (Bruker, Billerica, MA, USA)
operating at an incident microwave power of 18 mW, a modulation
amplitude of 0.4 G, a time constant of 1.28 ms, and a conversion
time of 10 ms.
Statistics
For behavioral studies, results are expressed as means with their
standard errors. All groups had 10 mice. The acquisition test scores
for T-maze (mean trials to make ﬁrst avoidance) and lever press
(number of reinforced lever presses) for each group were analyzed
with one-way analysis of variance (ANOVA) and a two-way analysis
of variance, respectively. Latencies to escape shock, activity, food
intake, and weight change were analyzed by a one-way ANOVA. The
control and treatment groups were compared with Tukey’s t-test or
Tukey’s HSD (Keppel and Zedeck 1989).
For BBB pharmacokinetic analysis, regression lines were
calculated by the least squares method and compared statistically
with the PRIZM 3.0 program (GraphPad Software, Inc, San Diego,
CA, USA). Regression lines are reported with their slope, standard
error of the mean, correlation coefﬁcient (r), the number of mice per
line (n), and the level of the statistical signiﬁcance (p). Means are
reported with their standard error and n.
Oxidative stress measures were analyzed by Student’s t-tests. A
value of p < 0.05 was considered statistically signiﬁcant.
Results
Effects of LA on cognition
Administration of LA improved acquisition as tested in the
T-maze footshock avoidance paradigm (Fig. 1a). The ANOVA
for the trials to ﬁrst avoidance measure indicated a signiﬁcant
effect (F2,27 ¼ 34.31, p < 0.001). Tukey’s t-test post-hoc
analysis revealed 12-month-old SAMP8 mice that had
received LA took signiﬁcantly fewer trials to reach criterion
than the 12-month-old SAMP8 mice which received saline.
The group of mice administered LA did not signiﬁcantly
differ from the 4-month-old SAMP8 mice administered
saline. The ANOVA for latencies to escape shock on the ﬁrst
trial did not indicate a signiﬁcant difference.
The ANOVA for activity in an open ﬁeld indicated a
statistically signiﬁcant effect (F2,27 ¼ 11.48, p < 0.001).
Tukey’s HSD post-hoc analysis indicated that the 4-month-
old SAMP8 mice (1897 ± 65 cm, n ¼ 10) were signiﬁcantly
more active in an open ﬁeld than the 12-month-old SAMP8
mice which received either saline (1583 ± 42 cm, n ¼ 10) or
LA (1656 ± 33 cm, n ¼ 11). The groups of 12-month-old
SAMP8 mice receiving either saline or LA did not differ
from one another.
The two-way ANOVA for the number of rewarded lever
presses showed a signiﬁcant effect for group (F2,260 ¼ 50.86,
p < 0.0001), day (F9,260 ¼ 42.80, p < 0.0001), and the
interactiongroup · day(F18,260 ¼ 4.18p < 0.0001).Tukey’s
post-hoc analysis indicated that 12-month-old SAMP8 mice
administered LA achieved signiﬁcantly more rewards on
days 7–9 compared with the mice administered saline
(Fig. 1b). Four-month-old SAMP8 mice achieved signiﬁ-
cantly more rewards than either of the 12 month groups on
days 7–10.
The ANOVA analyzing food intake in the mice administered
LA indicated a statistically signiﬁcant effect (F2,27 ¼ 3.62,
p < 0.05). Tukey’s HSD post-hoc analysis indicated that
the 12-month-old SAMP8 mice administered LA ate sig-
niﬁcantly more than the 4-month-old SAMP8 mice.
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not signiﬁcantly different from the 12-month-old SAMP8
mice administered LA nor the 4-month-old SAMP8 mice.
The ANOVA for body weight change during treatment did not
show a signiﬁcant effect (see Table 1).
Effects of NAC on cognition
The ANOVA analyzing T-maze acquisition showed a signiﬁ-
cant effect (F2,25 ¼ 61.29, p < 0.001). Tukey’s post-hoc
analysis showed that the 12-month-old SAMP8 mice which
received NAC performed signiﬁcantly better than the
12-month-old SAMP8 mice which received saline and were
not different from the 4 month SAMP8 mice (Fig. 1c). The
ANOVA for latencies to escape shock on ﬁrst trial did not show
a signiﬁcant effect.
The ANOVA for activity showed a signiﬁcant effect
F(2,26 ¼ 4.07, p < 0.05). Tukey’s post-hoc analysis showed
the only difference to be that the 4-month-old SAMP8
mice administered saline (1897 ± 65, n ¼ 10) were signiﬁ-
cantly more active than the 12-month-old SAMP8 mice
Fig. 1 Effects of LA and NAC on acquisition of T-maze footshock
avoidance and lever press. (a) LA improved acquisition of T-maze
footshock avoidance in 12-month-old SAMP8 mice. *Indicates that the
value differs from the saline treated 12-month-old SAMP8 mice at
p < 0.01. (b) LA improved acquisition of lever press in 12-month-old
SAMP8 mice. On days 7–9 of training, 12-month-old SAMP8 mice
receiving LA achieved more rewards than the day-matched 12-month-
old SAMP8 mice which received saline p < 0.01. Four-month-old
SAMP8 mice achieved more rewards than either 12-month-old
SAMP8 groups on days 7–10 p < 0.01. *p < 0.01 in comparison to
day-matched 12-month-old SAMP8 mice receiving saline. (c) NAC
improved acquisition of T-maze footshock avoidance in 12-month-old
SAMP8 mice. *Indicates that the value differs from the saline treated
12-month-old SAMP8 mice at p < 0.01. (d) NAC improved acquisition
of lever press in 12 month SAMP8 mice. On day 7, 12-month-old
SAMP8 mice receiving NAC achieved more rewards that the
12-month-old SAMP8 mice receiving saline *p < 0.01. Four-month-old
SAMP8 mice achieved more rewards than both 12-month-old SAMP8
groups on days 7–9, p < 0.01.
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old-mice given saline (1720 ± 52 cm, n ¼ 9) were not
different from 12-month-old mice given NAC.
The two-way ANOVA for rewarded presses in the lever
press study showed a signiﬁcant effect for group (F2,234 ¼
28.76, p < 0.0001), day (F8,234 ¼ 47.00, p < 0.0001), and
the interaction group · day (F2,8 ¼ 2.42 p < 0.002). Tukey’s
post-hoc analysis indicated that 12-month-old SAMP8 mice
administered NAC achieved signiﬁcantly more rewards on
day 7 compared with the 12-month-old SAMP8 mice
administered saline (Fig. 1d). Four-month-old SAMP8 mice
achieved signiﬁcantly more rewards than both 12-month-old
groups on the other days.
The ANOVA for food intake did not show a signiﬁcant
effect. The ANOVA for body weight change showed a
statistically signiﬁcant difference (F2,27 ¼ 9.57, p < 0.001).
Tukey’s HSD post-hoc analysis indicated that the 12-month-
old SAMP8 mice which received saline and NAC gained
weight, whereas the 4-month-old SAMP8 mice lost weight
(see Table 1).
Blood–brain barrier permeability to NAC
Figure 2(a) shows the relation between the log of levels of
radioactivity in arterial serum expressed as the percentage/
milliliter of injected dose (%Inj/mL) versus time after the
intravenousinjection of C-NAC. This relation had a slope of
)0.0222 and an intercept 1.051 (n ¼ 13, r ¼ 0.908,
p < 0.0001). This gave a half-time disappearance from blood
of 13.5 min and a volume of distribution of 8.89 mL.
Figure 2(b) shows the relation between the brain/blood
ratios (Am/Cpt) and exposure time for mice which received
C-NAC. This relation was statistically signiﬁcant (r ¼ 0.955,
n ¼ 13, p < 0.0001) with Ki ¼ 2.41 ± 0.226 lL/g-min and
Vi ¼ 39.3 ± 2.79 lL/g. The percentage of the injected dose
Fig. 2 (a) Clearance of NAC from blood after intravenous injection.
Half-time disappearance from blood was 13.5 min and the volume of
distribution was 8.89 mL. (b) Multiple-time regression analysis of NAC
transport across the BBB. The unidirectional inﬂux rate was measured
to be 2.41 ± 0.226 lL/g-min. (c) The percentage of an intravenously
injected dose taken up per gram of brain (%Inj/g) for NAC. Values
were about 0.4 %Inj/g. (d) Capillary depletion. Results show that most
of the NAC taken up by brain completely crossed the BBB to enter the
paranchymal space of the brain.






12 M P8 saline 5.11 ± 0.83
a,b + 0.07 ± 0.90
a
12 M P8 a-lipoic 5.78 ± 0.76
a ) 0.36 ± 1.22
a
4 M P8 saline 4.93 ± 0.63
b ) 0.54 ± 0.62
a
Study 2
12 M P8 saline 5.79 ± 0.84
a,b + 0.40 ± 0.47
a,b
12 M P8 N-acetylcysteine 6.07 ± 0.71
a + 0.88 ± 0.72
a
4 M P8 saline 4.99 ± 0.55
b ) 0.46 ± 0.84
b
M refers to age in months; P8 refers to SAMP8 mice.
a,bGroups with
different letters are signiﬁcantly differ p < 0.05 for that study.
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determined from the equation:
%Inj=g ¼ 10 3 ðAm=CptÞð%Inj=mLÞ:
These results show that about 0.4 %Inj/g was taken up by
brain.
C-NAC crossed the endothelial barrier of the cerebral
cortex as shown by recovery of radioactivity from the
parenchymal space of the brain (Fig. 2d). About 2.5 lL/g of
C-NAC was present in capillaries and may reﬂect uptake by
or binding to endothelium. For parenchyma, about 12.5 lL
of C-NAC was present, indicating that the majority of
C-NAC crossed the BBB.
Measures of oxidative stress
Protein carbonyl levels
To determine whether the protein carbonyl levels of cortical
synaptosomal membranes were increased in the 12-month-
old SAMP8 mice relative to those from 4-month-old SAMP8
mice, the 2,4-dinitrophenylhydrazone adducts were meas-
ured immunochemically. The results showed that the protein
carbonyl levels of brain proteins in 12-month-old SAMP8
were signiﬁcantly greater than those of 4-month-old SAMP8
by 29% (Fig. 3aA; p < 0.01). However, treatment with LA
reduced this difference to a statistically non-signiﬁcant 17%
increase (Fig. 3aB).
W/S ratio
Consistent with the result for protein carbonyl levels, the
W/S ratio was decreased signiﬁcantly in the synaptosomal
membrane proteins from 12-month-old SAMP8 mice when
compared with 4-month-old SAMP8 mice (Fig. 3bA;
p < 0.001). As noted above, the W/S ratio is lowered by
oxidative stress (Hensley et al. 1994; Hall et al. 1995a; Hall
et al. 1995b; Hall et al. 1995c; Butterﬁeld et al. 1997).
Treatment with LA abolished the difference between aged
and young SAMP8 mice (Fig. 3bB).
TBARS
Increased TBARS levels were observed in the brains of
12-month-old SAMP8 mice when compared with 4-month-
old SAMP8 mice (Fig. 3cA; p < 0.05). This result suggested
an increased lipid peroxidation in 12-month-old SAMP8
mice. Treatment with LA abolished the difference between
young and old mice (Fig. 3cB).
Discussion
Oxidative stress and damage induced by free radicals has
been proposed as an important mechanism for both normal
aging and the cognitive decline of neurodegenerative diseases
(Zs-Nagy 1978; Zs-Nagy 1990). Here, we investigated
whether antioxidant treatment could reverse the cognitive
decline and oxidative damage seen in the aged SAMP8
mouse. This strain of mouse starts at about 6–8 months of
age to overexpress Ab, the peptide postulated to be the cause
of AD (Kumar et al. 2000; Morley et al. 2000). With Ab
overexpression, these mice develop cognitive impairments
which precedes by several months physical decline (Takeda
Fig. 3 (a) Protein carbonyl levels for 4 and 12-month-old SAMP8
mice. A, Untreated mice. Error bars indicate SEM for eight animals in
each group. B, LA treated mice. Error bars indicate SEM for seven
animals in each group. Measured value is normalized with the
4-month-old values. *p < 0.01. (b) W/S ratios for 4 and 12-month-old
SAMP8 mice. A, Untreated mice. Error bars indicate SEM for six and
seven animals, respectively. B, LA-treated mice. Error bar indicates
SEM for six animals in each group. Measured value is normalized to
the 4-month-old values. *p < 0.001. (c) TBARS of 4 and 12-month-old
SAMP8 mice. (i) Untreated mice. Error bars indicate SEM for seven
and six animals, respectively. (ii) LA treated mice. Error bar indicates
SEM for seven and six animals in each group. Measured value is
normalized with the 4-month-old values. *p < 0.01.
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Tanaka et al. 1998; Butterﬁeld et al. 2001b; Morley et al.
2002). By 12 months of age, SAMP8 mice are healthy but
have developed severe impairments in learning and memory,
which are reversed by antibody or antisense directed at Ab
(Kumar et al. 2000; Morley et al. 2000; Banks et al. 2001).
Other strains of mice at this age show little or no cognitive
decline.
Here, we found that both LA and NAC could reverse
impaired learning in 12-month-old SAMP8 mice in two
separate behavioral paradigms. In the footshock avoidance
T-maze, LA and NAC each returned learning to a level that
was not different from unimpaired 4-month-old SAMP8
mice. LA and NAC were less effective in the lever press test.
Although either antioxidant improved performance in this
food-reward paradigm to a statistically signiﬁcant degree,
12-month-old SAMP8 mice still underperformed when
compared with 4-month-old mice.
The reason why antioxidants were not as potent in a food-
reward-based learning paradigm is not clear, but one
possibility is that anorexia of aging, which is thought to be
unrelated to free radical production (Morley 2001; Morley
1997). Antioxidant treatment did not affect motor activity,
response to shock, or body weight. Effects on these
parameters could have acted as confounders and an absence
of effect further supports a direct action of antioxidants on
cognition.
These results are similar to those that found diets rich in
antioxidants improved learning in aged rats (Bickford et al.
2000). In addition, two of three diets tested signiﬁcantly
increased brain concentrations of glutathione, the most potent
known intracellular antioxidant. LA and NAC are precursors
to glutathione (Overton and Fisher 1991; Wernerman and
Hammarqvis 1996; Exner et al. 2000). The cognitive
impairments of the SAMP8 mouse, however, are much
greater than those occurring with normal aging.
The ability of antioxidants to reverse cognitive impair-
ments depends upon their ability to reach the brain. This, in
turn, depends on an ability to cross the BBB. The accumu-
lation of free fatty acids (FFA) in brain results from a complex
interplay between free and serum protein bound FFA, BBB
inﬂux transporters, BBB efﬂux transporters, and brain
utilization (Banks et al. 1997b; Rapoport and Robinson
1995). Amino acid uptake by the brain depends on BBB
transporters such as the one for large neutral amino acids
(Davson and Segal 1996). Here, we showed that NAC entered
the brain at a rate of about 2.41 lL/g-min, a modest rate in
comparison to essential amino acids and about the same rate
as many centrally active peptides (Begley 1994; Banks et al.
1995a; Banks et al. 1995b; Banks et al. 1997a; Banks 1999).
Results of the capillary depletion experiment showed NAC
could completely cross the capillary wall to enter the brain
tissue and extracellular space. To determine the percentage of
an intravenous dose of NAC taken up by a g of brain (%Inj/g),
we ﬁrst had to calculate circulating pharmacokinetic para-
meters (shown in Fig. 5). These values and the inﬂux
characteristics were then used to calculate %Inj/g. The results
showed that about 0.4% of an injected dose was taken up by
brain. This is about 4, 5, 20, and 200 times greater than the
values for acetaminophen, interleukin-1 alpha, morphine, and
domoic acid, respectively (Banks et al. 1991; Preston and
Hynie 1991; Banks and Kastin 1994; Courade et al. 2001), all
CNS-active agents. Therefore, the amount of NAC transpor-
ted across the BBB is well within the therapeutic range of
compounds known to exert effects on the brain.
We assessed the effect of antioxidant treatment on
measures of oxidative stress in the aged SAMP8 mouse.
We found that 12-month-old SAMP8 mice had more
oxidative stress than 4-month-old SAMP8 mice. This
conﬁrms previous ﬁndings from another colony of SAMP8
mice and is consistent with studies showing that the SAMP8
mouse accumulates more oxidative damage than animals
which age normally (Butterﬁeld et al. 1997; Stadtman 1992;
Hensley et al. 1994; Fujibayashi et al. 1998). Additionally,
the brains of aged SAMP8 mice have a 44–50% decrease in
delta-9 desaturase activity and a corresponding decrease in
unsaturated free fatty acids. (Butterﬁeld et al. 2001a).
The results suggest that oxidative stress is widespread,
affecting measures of protein oxidation, lipid peroxidation,
and oxidation-dependent changes in membrane protein
conformation. These parameters were all reversed by
treatment with LA. Ames and coworkers have shown that
LA is able to partially reverse memory loss in normal aging
rats by delaying mitochondrial dysfunction and RNA/DNA
oxidation (Liu et al. 2002). Mitochondrial dysfunction is
accompanied by a leakage into cytoplasm of O2 and H2O2.
That LA is readily taken up into mitochondria where it
acts as a cofactor in oxidative decarboxylation of a-keto
acids has led to the view that LA maybe a useful
therapeutic agent in diseases characterized by mitochondria
dysfunction or oxidative stress (Packer et al. 1997; Lynch
2001).
LA derives its antioxidant capability from its ability to (i)
act as a scavenger of reactive oxygen species (ROS); (ii)
chelate metals; and (iii) recycle endogenous antioxidants
(Lynch 2001). LA can scavenge singlet oxygen, H2O2,O H
Æ,
NO and ONOO
). The reduced form of LA, dihyrolipoic acid,
can further scavenge O 
2 and peroxyl radicals (Kagan et al.






2+. Therefore, LA can inhibit
ascorbate-induced production of H2O2 by Cu
+ (Ou et al.
1995). LA can recycle endogenous antioxidants, such as
GSH(Ou et al. 1995) and vitamin C (Drake et al. 2002),
which regenerate vitamin E. GSH, vitamin C, and vitamin E
all protect the brain from oxidative stress (Drake et al. 2002).
In conclusion, we found treatment with the antioxidants
LA and NAC reversed the age-related cognitive impairment
in SAMP8 mice. These substances probably act directly on
1180 S. A. Farr et al.
  2003 International Society for Neurochemistry, J. Neurochem. (2003) 84, 1173–1183the brain, as NAC crossed the BBB and accumulated in brain
to a signiﬁcant degree. Treatment with LA reversed the
oxidative stress seen in 12-month-old SAMP8 mice to levels
that were not different from those seen in 4-month-old
SAMP8 mice. These results support the hypothesis that
oxidative stress can lead to cognitive dysfunction and
provide evidence for a therapeutic role for antioxidants.
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